Leiomyosarcoma of the larynx is an extremely rare neoplasm ; only about 50 cases have been reported in the English-language literature. We report a new case of laryngeal leiomyosarcoma in a 65-year-old man. The metastatic work-up was negative, and thepatient underwent total laryngectomy. He remained disease-free J2 months postoperatively.
(48.4 %) ; supraglottis, 10 (32.3%) ; supraglottis-glottis, 2 (6.5%); subglottis, 2; supraglottis-glottis-subglottis, 1 (3.2%); and glottis-subglottis, 1. 4 Smoking and alcohol use are not considered to be risk factors for laryngeal leiomyosarcoma. ' In this article , we report a new case of laryngeal leiomyosarcoma that was successfully treated with total laryngectomy.
Case report
A 65-year-old man was referred to our head and neck clinic for evaluation ofa 5-month history of worsening hoarseness and a 3-day history of breathing difficulty. He had no history ofsmoking or alcohol intake. Physical examination revealed obvious stridor at rest, but he was able to achie ve oxygen saturation on room air. Fiberoptic laryngoscopy revealed that a polypoid mass was occupying almost the entire glottic space. A very narrow glottic space could be seen posteriorly. The large size of the tumor prevented us from identifying its site of origin or the degree of vocal fold mobility. No cervical lymph nodes were palpable.
Emergency tracheotomy with local anesthesia was performed to secure the airway. Suspension laryngoscopy showed that the polypoid lesion had arisen from the right true vocal fold and anterior commissure. Subglottic extension could not be determined. The surface of the mass was smooth. The left vocal fold was clear. Examination of multiple biopsy specimens revealed that the histologic picture was consistent with a leiomyosarcoma ( figure 1, A) . Immunohistochemical studies demonstrated positive staining with antibodies to smooth-muscle actin (figure 1, B) and vimentin , and negative staining with S-100, cytokeratin AE1/AE3 , and cytokeratin MNF.
Computed tomography (CT) ofthe neck confirmed that the well-enhancing mass originated in the right true vocal fold and anterior commissure (figure 2). The mass had infiltrated the entire glottis, but we noted only minimal subglottic extent and no supraglottic involvement. No cervical lymphadenopathy or destruction of the thyroid cartilage was evident, and the chest x-ray was clear. Ultrasonography ofthe liver found no evidence of metastatic disease, and the results ofliver function tests were within normal limits. The patient underwent total laryngectomy, and his recovery was uneventful. He was fitted with an electrolarynx, which helped him maintain satisfactory communication. One year following surgery, he was well and exhibited no evidence of local or distant tumor.
Discussion
The morphologic diagnosis oflaryngealleiomyosarcoma can be difficult to make on the basis of convent ional microscopy alone . Morpholo gic findings should be supported by immunohistochemistry and ultrastructural investigations whenever possible. Histopathologically, laryngeal leiomyosarcoma is characterized by prominent interlacing Mitot ic activity is the primary mark er for a diagnosis of leiomyos arcom a, but cellular atypi a is also taken into the account. Neoplasms with 5 or more mitoses per 10 high-power field and moderate to marked cellular atypia are considered to represent leiomyo sarcom a.' Ther e have been reports of leiomyosarcoma associated with Epstein-Barr virus in immunosuppressed patients ." In determining the extent of these tumors and when planning surgery, CT and magnetic resonance imaging are useful becaus e they not only indicate the extent of the primary lesion, they provid e reliable information regard ing cervical lymphadenopathy, as well.
The paucity of reports of larynge al leiomyosarcoma in the literature has hindered efforts to reach valid conclusions about different modalities of treatment. However, one generally accepted treatment is curat ive resection of the tumor with wid e surgical margins . Lim ited surgical experience in dealing with larynge al leiomy osarcoma and the unpredictable behavior of this diseas e have prompt ed some head and neck surgeons to be aggressive and treat extensive lesions with total laryngectomy rather than with partial surgery. However, some recent reports suggest that endolaryngeal resection or partial laryngectomy results in better funct ional outcomes whenev er the extent of the disease permits .' Rad ical neck dissection is usually withheld unless cervical lymphadenopathy is obv ious. Reported Therapy .Treatment ofrhabdomyo ma consists primarily of comp lete excision with preservation ofthe surrounding tissues. Recurrenc es are most comm only associated with incomple te excision and have been reported to occur in more than one-third of cases.' Follow-up must be longterm, as recurr ence can occur after as long as 35 years. Tumor recurrence also should alert one to the possibilit y of rhabdomyosarcoma. rates oflocal recurr ence following surgical excision range from 35 to 50%. 9 Rad iotherapy as a pr imary therapeutic mod ality is of limited value , but it may have a role as an adjuvant therapy and as a treatment for residual or recurrent diseas e. Kleins asser and Glanz reported that radioth erapy alone is completely ineffective." The role of chemoth erapy is also limited.
According to the literature, the longe st period of postoperative disease-free survival is II years." The risk of recurrence in patie nts treated for leiomyos arcoma extends long after treatment , so patients should undergo long-term follo w-up.
